Exhibit 99.8
Gilead Tweets (@Gilead), August 28, 2017
Kite has leading investigational product in a disease w/ unmet medical need; approval process underway in U.S. and EU https://t.co/KAtiQS2rlT
Exhibit 99.8
Gilead Tweets (@Gilead), August 28, 2017
Kite has leading investigational product in a disease w/ unmet medical need; approval process underway in U.S. and EU https://t.co/KAtiQS2rlT
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.